Dabigatran Impurity 77 | CAS 1771756-20-7 - Request Quote
Dabigatran Impurity 77
| SZ CAT No: | SZ-D012180 |
| CAS No | 1771756-20-7 |
| Mol.F. | C16H18N4O3 |
| Mol.Wt. | 314.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 77 is chemically 3-(3-Amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoic acid. Dabigatran Impurity 77 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 77 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1771756-20-7
Purchase 1771756-20-7
Order 1771756-20-7
Enquire 1771756-20-7
price of 1771756-20-7
1771756-20-7 Supplier
1771756-20-7 Manufacturer
1771756-20-7 Exporter
buy high quality Dabigatran Impurity 77
Purchase Dabigatran Impurity 77
Dabigatran Impurity 77 suppliers
Dabigatran Impurity 77 manufacturers
Dabigatran Impurity 77 price
Order Dabigatran Impurity 77
Enquire Dabigatran Impurity 77
Dabigatran Impurity 77 cost
Dabigatran Impurity 77 Supplier
Dabigatran Impurity 77 Distributor
Dabigatran Impurity 77 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 77 for ANDA Filing
Dabigatran Impurity 77 for Forced Degradation Studies
Dabigatran Impurity 77 Identification Standards
Dabigatran Impurity 77 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.